Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Surveillance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 0 results

Large-scale testing (Phase 3)UnknownNCT04682210
What this trial is testing

Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection

Who this might be right for
HCCAdjuvant TherapyImmunotherapy
Sun Yat-sen University 246
Not applicableUnknownNCT02854241
What this trial is testing

Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance

Who this might be right for
CirrhosisHepatocellular Carcinoma
Seoul National University Hospital 40
Not applicableNot Yet RecruitingNCT07764835
What this trial is testing

Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis B+2 more
D'Or Institute for Research and Education 300
Not applicableUnknownNCT02514434
What this trial is testing

Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC]

Who this might be right for
Compensated Liver Cirrhosis
Yonsei University 416
Not applicableStudy completedNCT05690451
What this trial is testing

Non-contrast Abbreviated MRI for Secondary Surveillance of HCC

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 210